Literature DB >> 11066085

Promoter demethylation accompanies reactivation of the HOX11 proto-oncogene in leukemia.

P M Watt1, R Kumar, U R Kees.   

Abstract

Despite considerable work on the epigenetic control of tumor suppressor genes, little is known about the potential role of promoter CpG demethylation in the activation of oncogenes in lymphoid tumors. The HOX11 proto-oncogene is frequently activated in T-cell acute lymphoblastic leukemia (T-ALL). HOX11 activation can occur in the absence of translocation of the gene to the T-cell receptor locus (Salvati et al., 1995), implying that activation mechanisms must be involved other than the juxtaposition of the gene to adjacent enhancing sequences. We tested whether the methylation status of the proximal promoter was correlated with expression status in T-ALL and found that, in all cases, expression of HOX11 in T-ALL was associated with extensive demethylation of the proximal HOX11 promoter, regardless of whether or not translocation was involved. In contrast, cells that did not express HOX11 showed a more methylated pattern of CpG residues in the proximal promoter. Methylation of this sequence in vitro was sufficient to silence the proximal promoter. We propose a model in which the selection of leukemia clones via a pathway involving HOX11 expression requires the demethylation of its promoter as a prerequisite for additional gene activation mechanisms. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11066085     DOI: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1050>3.0.co;2-y

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  15 in total

Review 1.  Molecular targets of epigenetic regulation and effectors of environmental influences.

Authors:  Supratim Choudhuri; Yue Cui; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2010-04-08       Impact factor: 4.219

2.  BORIS binding to the promoters of cancer testis antigens, MAGEA2, MAGEA3, and MAGEA4, is associated with their transcriptional activation in lung cancer.

Authors:  Sheetal Bhan; Sandeep S Negi; Chunbo Shao; Chad A Glazer; Alice Chuang; Daria A Gaykalova; Wenyue Sun; David Sidransky; Patrick K Ha; Joseph A Califano
Journal:  Clin Cancer Res       Date:  2011-05-10       Impact factor: 12.531

3.  Cre/lox-regulated transgenic zebrafish model with conditional myc-induced T cell acute lymphoblastic leukemia.

Authors:  David M Langenau; Hui Feng; Stephane Berghmans; John P Kanki; Jeffery L Kutok; A Thomas Look
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-12       Impact factor: 11.205

Review 4.  Cancer epigenetics reaches mainstream oncology.

Authors:  Manuel Rodríguez-Paredes; Manel Esteller
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

5.  Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer.

Authors:  Wojciech K Mydlarz; Patrick T Hennessey; Joseph A Califano
Journal:  Expert Opin Med Diagn       Date:  2010-01-01

Review 6.  Targeting Epigenetics in Cancer.

Authors:  Richard L Bennett; Jonathan D Licht
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-06       Impact factor: 13.820

7.  Genetic and epigenetic determinants mediate proneness of oncogene breakpoint sites for involvement in TCR translocations.

Authors:  N S D Larmonie; A van der Spek; A J J C Bogers; J J M van Dongen; A W Langerak
Journal:  Genes Immun       Date:  2013-12-05       Impact factor: 2.676

Review 8.  Epigenetic Deregulation of Apoptosis in Cancers.

Authors:  Ezgi Ozyerli-Goknar; Tugba Bagci-Onder
Journal:  Cancers (Basel)       Date:  2021-06-27       Impact factor: 6.639

9.  Coordinated activation of candidate proto-oncogenes and cancer testes antigens via promoter demethylation in head and neck cancer and lung cancer.

Authors:  Ian M Smith; Chad A Glazer; Suhail K Mithani; Michael F Ochs; Wenyue Sun; Sheetal Bhan; Alexander Vostrov; Ziedulla Abdullaev; Victor Lobanenkov; Andrew Gray; Chunyan Liu; Steven S Chang; Kimberly L Ostrow; William H Westra; Shahnaz Begum; Mousumi Dhara; Joseph Califano
Journal:  PLoS One       Date:  2009-03-23       Impact factor: 3.240

Review 10.  Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.

Authors:  Mohammad Reza Karimzadeh; Peyman Pourdavoud; Naeim Ehtesham; Mohaddese Qadbeigi; Masood Movahedi Asl; Behrang Alani; Meysam Mosallaei; Bahram Pakzad
Journal:  Cancer Gene Ther       Date:  2020-08-10       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.